Drugs / CIK
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03146637 Comparator | May 2017 → Jan 2021 | liver cancer | Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03146637 ↗ |
| Modality | Cell therapy | “Traditional CIK were infused for 3 days” NCT03146637 ↗ |